What Science Can Do

AstraZeneca is a global pharmaceutical business with a science-led and patient-focused value proposition, committed to excellence in the discovery, development, manufacturing and commercialisation of prescription medicines in Oncology, Rare Disease (Alexion), and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Vaccines & Immune Therapies. Based in Cambridge, UK, AstraZeneca operates in over 125 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on social media @AstraZeneca.

"I Inspired by our purpose and values, we’re transforming the future
of healthcare by unlocking the power of what science can do – for people, society and the planet."
Pascal Soriot, CEO

Revenue: 54.1 billion USD (2024)
Employees: 89 900 (2023)
Founded: 1999 (Astra founded 1913)
Public/list: London, Stockholm & New York
Chairman: Michel Demaré
Principal owners BlackRock, Inc., Wellington Management Group LLP, Investor AB, The Capital Group